Detalhe da pesquisa
1.
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
Mol Cell
; 66(5): 698-710.e5, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506461
2.
BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia.
Biochem J
; 480(2): 161-176, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719792
3.
Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival.
Mol Cell
; 42(1): 23-35, 2011 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21353614
4.
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.
Immunity
; 31(1): 84-98, 2009 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19559631
5.
Relevance of necroptosis in cancer.
Immunol Cell Biol
; 95(2): 137-145, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27922620
6.
Exploring the utility of human DNA methylation arrays for profiling mouse genomic DNA.
Genomics
; 102(1): 38-46, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23639479
7.
Generation of stable suspension producer cell lines for serum-free lentivirus production.
Biotechnol J
; 19(5): e2400090, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719592
8.
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.
Pharmaceutics
; 14(1)2022 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35057108
9.
Crossing paths: interactions between the cell death machinery and growth factor survival signals.
Cell Mol Life Sci
; 67(10): 1619-30, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20157838
10.
Apoptosomes: protease activation platforms to die from.
Trends Biochem Sci
; 31(5): 243-7, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16595176
11.
Future Therapeutic Directions for Smac-Mimetics.
Cells
; 9(2)2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053868
12.
Combinatorial Treatment of Birinapant and Zosuquidar Enhances Effective Control of HBV Replication In Vivo.
Viruses
; 12(8)2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32824616
13.
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.
Blood Adv
; 4(20): 5062-5077, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080008
14.
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction.
Nat Commun
; 11(1): 3150, 2020 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561755
15.
'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid Leukemia.
Trends Mol Med
; 23(3): 264-281, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196625
16.
Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death.
Proteomics Clin Appl
; 11(9-10)2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447382
17.
High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression.
Blood Adv
; 1(15): 1067-1079, 2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296749
18.
Lentiviral Vectors to Analyze Cell Death Regulators.
Methods Mol Biol
; 1419: 265-76, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27108445
19.
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.
Sci Transl Med
; 8(339): 339ra69, 2016 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27194727
20.
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.
Cancer Cell
; 29(2): 145-58, 2016 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26859455